
|Articles|April 18, 2019
The Era of PARP Inhibition in Cancer Management - Patient Selection and Deciding When to Use in Treatment
https://www.pharmacytimes.org/on-demand/the-era-of-parp-inhibition-in-cancer-management-patient-selection-and-deciding-when-to-use-in-treatment-enduring
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Azacitidine/Venetoclax Combo Data Challenge Chemo in Fit Patients With AML
2
'Tis the Season: SABCS 2025 to Highlight Latest Advances Across the Breast Cancer Continuum
3
Adolescents Saw Mental Health Gains After School Reopened Post Pandemic
4
Expanding Precision Care for Alzheimer Disease, Multiple Sclerosis
5













































